How much does a box of Olaparib/Olaparib cost? The latest market prices and medical insurance coverage in 2025
Olaparib is a new type of targeted drug mainly used to treat ovarian cancer, breast cancer and certain types of pancreatic and prostate cancer that carry BRCA gene mutations. This type of drug is a type of PARP inhibitor. It interferes with the DNA repair mechanism of cancer cells and promotes cancer cell death, thereby effectively controlling the progression of tumors. Studies have shown that olaparib can significantly improve progression-free survival (PFS) and quality of life for patients whose disease progresses after multiple treatments.

Regarding price, the original drug of Lynparza has been launched in the Chinese market and is included in Class B medical insurance, but its scope of application is limited to specific indications and patient groups. At present, common specifications include100mg×7 plates×8 tablets and 150mg×56 tablets. The price of each box is about more than 6,000 yuan. This kind of pricing is much more favorable than in foreign markets. For example, in the United States, the price of olaparib may reach about 8,000 US dollars per box, which puts a heavy burden on patients. Therefore, many patients will consider other purchasing channels to reduce the cost of treatment.
In addition to original drugs, there are also generic versions of drugs in many countries on the overseas market, such as Laos and Bangladesh. These generic drugs are similar to the original drugs in terms of ingredients and therapeutic effects, and are usually more affordable. Taking the specification of 50 mg × 112 tablets as an example, each box of overseas generic drugs sells for about more than 2,000 yuan. For patients with limited financial conditions, this is undoubtedly a more feasible choice. However, when using generic drugs, patients need to ensure the legality of the purchasing channel and the quality of the drugs to avoid affecting the treatment effect. For more information on overseas drug prices and related information, please consult Yaode Medical Consultant.
Reference materials:https://www.lynparza.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)